Stocktoria

PFIZER INC PFE

NYSE · stock · Pharmaceutical Preparations · website · IPO 1944-01-17 · LEI

PFIZER INC financials (annual)

Revenue
$52.82B $52.55B $40.83B $40.91B $41.65B $81.29B $101.17B $59.55B $63.63B $62.58B 2016201720182019202020212022202320242025
Net income
$7.21B $21.31B $11.15B $16.03B $9.16B $21.98B $31.37B $2.12B $8.03B $7.77B 2016201720182019202020212022202320242025
Free cash flow
$14.37B $14.85B $13.84B $10.54B $12.18B $30.21B $26.03B $4.79B $9.84B $9.07B 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$62.6B$63.6B$59.6B$101.2B$81.3B$41.7B$40.9B$40.8B$52.5B$52.8B
SG&A expense$13.8B$14.7B$14.8B$13.7B$12.7B$11.6B$12.7B$12.6B$14.8B$14.8B
Interest expense$2.7B$3.1B$2.2B$1.2B$1.3B$1.4B$1.6B$1.3B$1.3B$1.2B
Income tax-$266.0M-$28.0M-$1.1B$3.3B$1.9B$370.0M$583.0M-$266.0M-$9.0B$1.1B
Net income$7.8B$8.0B$2.1B$31.4B$22.0B$9.2B$16.0B$11.2B$21.3B$7.2B
EPS (diluted)$1.36$1.41$0.37$5.47$3.85$1.63$2.82$1.87$3.52$1.17
Operating cash flow$11.7B$12.7B$8.7B$29.3B$32.9B$14.4B$12.6B$15.8B$16.8B$16.2B
Free cash flow$9.1B$9.8B$4.8B$26.0B$30.2B$12.2B$10.5B$13.8B$14.8B$14.4B
Cash & equivalents$1.1B$1.0B$2.9B$416.0M$1.9B$1.8B$1.1B$1.1B$1.3B$2.6B
Inventory$10.7B$10.9B$10.2B$9.0B$9.1B$8.0B$7.1B$7.5B$7.6B$6.8B
Total assets$208.2B$213.4B$226.5B$197.2B$181.5B$154.2B$167.6B$159.4B$171.8B$171.6B
Total liabilities$121.4B$124.9B$137.2B$101.3B$104.0B$90.8B$104.1B$95.7B$100.1B$111.8B
Shareholders' equity$86.8B$88.5B$89.3B$95.9B$77.5B$63.5B$63.4B$63.8B$71.7B$59.8B

Growth · year-over-year · Revenue CAGR 1.9%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth-1.6%+6.8%-41.1%+24.5%+95.2%+1.8%+0.2%-22.3%-0.5%
Net income growth-3.2%+279.0%-93.2%+42.7%+140.0%-42.8%+43.7%-47.7%+195.3%+3.7%
EPS growth-3.5%+281.1%-93.2%+42.1%+136.2%-42.2%+50.8%-46.9%+200.9%+5.4%
Free cash flow growth-7.7%+105.2%-81.6%-13.8%+148.1%+15.5%-23.8%-6.8%+3.3%+8.1%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.